|
|||
|
May 10, 2023 Source: American Vanguard news release Eric Wintemute, Chairman and CEO of American Vanguard, stated: "During 2023, we expect to achieve higher adjusted EBITDA (between $84MM - $86MM) than in 2022, despite a first quarter setback arising from delays in restarting our supply chain, which is now back at capacity. "After experiencing multiple delays, our China-based supplier was unable to deliver intermediates in sufficient quantities for our leading corn soil insecticide, Aztec, until early 2023. As a result, we were only able to produce and sell about one-third of seasonal demand for that product. "This, coupled with a glut of generic herbicides (not sold by the Company) in the distribution channel, led to lower sales of domestic crop products during the quarter. While our domestic non-crop and international businesses recorded higher sales, the decrease in sales of higher-margin US crop products led to lower overall profitability." To read the entire report click here. Tweet |
|
|
||||||||||||||||